Amanta Healthcare boosts sterile manufacturing with capacity expansionIllustrative image – not actual.

Amanta Healthcare, specialising in the development, manufacturing and marketing of sterile liquid products, is advancing its growth strategy through capacity expansion and operational efficiency initiatives.

The company focuses on producing large volume parenterals (LVPs) and small volume parenterals (SVPs), catering to domestic and export requirements, has highlighted key operational and business performance updates for Q1 FY27. Amanta is progressing with key expansion projects, which are expected to improve manufacturing scale in India. The SteriPort facility is scheduled for commissioning by Q2/FY27, while the SVP expansion is planned for completion by Q4 of FY27.

Amanta Healthcare is also implementing a captive solar power project to enhance energy efficiency, reduce operational costs and strengthen its sustainability efforts.

← All latest storiesBack to top →